Status:
COMPLETED
A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis
Lead Sponsor:
Ahn-Gook Pharmaceuticals Co.,Ltd
Conditions:
Acute Bronchitis
Eligibility:
All Genders
19-75 years
Phase:
PHASE3
Brief Summary
A Multicenter, Randomized, Double-Blind, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of AGS Compared to AGU for Acute Bronchitis
Eligibility Criteria
Inclusion
- Both gender, 19 years ≤ age ≤ 75 years
- BSS(Bronchitis Severity Score) ≥ 5point at Visit 2 (Randomized Visit)
- Patients without fever based on Visit 2(Randomized Visit)
- Those who can comply with the requirements of clinical trials
- Written consent voluntarily to participate in this clinical trial
Exclusion
- Patients with respiratory and systemic infections requiring systemic antibiotic therapy
- Patients with bleeding tendency or coagulation disorder
- Patients who investigators determines to severe respiratory disease that would interfere with study assessment
- Those who have participated in other clinical trials within 4 weeks before participating in clinical trials
- In case the investigator judges that it is not suitable for the subject of this clinical trial for other reasons
Key Trial Info
Start Date :
October 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2020
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT05344638
Start Date
October 17 2019
End Date
July 29 2020
Last Update
April 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Medical Center
Seoul, South Korea